The Great Isotope Debate: Which Therapeutic Radionuclide Will Define the Next 5 Years of TRP Development? Seven Isotope Specialists, Seven Perspectives.
Targeted Radiopharmaceuticals Summit EU 2026 · 1 December 2026 · 09:00
The Great Isotope Debate: Which Therapeutic Radionuclide Will Define the Next 5 Years of TRP Development? Seven Isotope Specialists, Seven Perspectives. was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 1 December 2026 in London, with 7 speakers on record.
Speakers
- Chaitanya Divgi — Speaker Senior Expert - Strategic Therapeutic Innovation, Novartis
- Mohamad Haqiqian — Speaker PET Radiopharmacy Production & QC Analyst, Radiation Safety Supervisor, Curium Pharma
- Michael Method — Speaker Chief Medical Officer, Bicycle Therapeutics
- Rich Edwards — Speaker Chief Technology Officer, Nuclide Therapeutics
- Ajaaz Hussain — Speaker Radiopharmaceutical Scientist, The Royal Marsden NHS
- Guangzhou Han — Speaker Chief Scientific Officer, RadAlliance Therapeutics Inc
- Waisi Eng — Speaker Chief Technology Officer, Norroy North America Inc.